Fig. 6.

Immune infiltration and chemotherapy sensitivity analysis. A heatmap depicts the correlation between ETS2, TOMM40, CMTM2, FH, TNFSF10 and 22 immune infiltrating cells expression. B shows the comparison between high and low-risk groups in the expression of 22 immune infiltrating cells (*P < 0.05; ** P < 0.01; *** P < 0.001). C shows the levels of stromal, immune and ESTIMATE scores in different NRGMS groups according to the ESTIMATE algorithm. D shows the expression of immune checkpoints in the high and low-risk groups. The drugs associated with the high and low-risk groups of the model were visualized and E–J shows the box plot of IC50 expression in the high and low-risk groups for SL.0101.1, ABT.888, Axitinib, AZ628, Embelin and FH535, respectively